(5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one

C108H138N28O14 — CID 157413338

IUPAC(5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one
SMILESC[C@H]1[C@@H]2CCc3c(nn(C)c3-c3nnn(C)n3)[C@@]2(C)CCC12OCCO2.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)C/C(=C/O)C(=O)[C@@H](C)[C@@H]2CC3)o1.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)CCC(=O)[C@@H](C)[C@@H]2CC3)o1.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)CCC4(OCCO4)[C@@H](C)[C@@H]2CC3)o1.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)Cc4cnoc4[C@@H](C)[C@@H]2CC3)o1.[C-]#[N+]C1C[C@]2(C)c3nn(C)c(-c4nnc(C)o4)c3CC[C@H]2[C@H](C)C1=O
InChIInChI=1S/C19H26N4O3.C18H26N6O2.2C18H21N5O2.C18H22N4O3.C17H22N4O2/c1-11-14-6-5-13-15(17-21-20-12(2)26-17)23(4)22-16(13)18(14,3)7-8-19(11)24-9-10-25-19;1-11-13-6-5-12-14(16-19-22-24(4)21-16)23(3)20-15(12)17(13,2)7-8-18(11)25-9-10-26-18;1-9-13-6-5-12-14(17-21-20-10(2)24-17)23(4)22-16(12)18(13,3)7-11-8-19-25-15(9)11;1-9-12-7-6-11-14(17-21-20-10(2)25-17)23(5)22-16(11)18(12,3)8-13(19-4)15(9)24;1-9-13-6-5-12-14(17-20-19-10(2)25-17)22(4)21-16(12)18(13,3)7-11(8-23)15(9)24;1-9-12-6-5-11-14(16-19-18-10(2)23-16)21(4)20-15(11)17(12,3)8-7-13(9)22/h11,14H,5-10H2,1-4H3;11,13H,5-10H2,1-4H3;8-9,13H,5-7H2,1-4H3;9,12-13H,6-8H2,1-3,5H3;8-9,13,23H,5-7H2,1-4H3;9,12H,5-8H2,1-4H3/b;;;;11-8-;/t11-,14-,18-;11-,13-,17-;9-,13-,18-;9-,12-,13?,18-;9-,13-,18-;9-,12-,17-/m000000/s1
InChIKeyBONXUZHUOWPHBD-NFCMHCCRSA-N
MW2052.47 g/mol
LogP15.06
Rot. Bonds6

About (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one

(5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one (PubChem CID 157413338) has the molecular formula C108H138N28O14 and a molecular weight of 2052.47 g/mol. Its IUPAC name is (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one.

Molecular Properties

Compound Name(5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one
PubChem CID157413338
Molecular FormulaC108H138N28O14
Molecular Weight2052.47 g/mol
Exact Mass2051.09
IUPAC Name(5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one
SMILESC[C@H]1[C@@H]2CCc3c(nn(C)c3-c3nnn(C)n3)[C@@]2(C)CCC12OCCO2.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)C/C(=C/O)C(=O)[C@@H](C)[C@@H]2CC3)o1.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)CCC(=O)[C@@H](C)[C@@H]2CC3)o1.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)CCC4(OCCO4)[C@@H](C)[C@@H]2CC3)o1.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)Cc4cnoc4[C@@H](C)[C@@H]2CC3)o1.[C-]#[N+]C1C[C@]2(C)c3nn(C)c(-c4nnc(C)o4)c3CC[C@H]2[C@H](C)C1=O
InChIInChI=1S/C19H26N4O3.C18H26N6O2.2C18H21N5O2.C18H22N4O3.C17H22N4O2/c1-11-14-6-5-13-15(17-21-20-12(2)26-17)23(4)22-16(13)18(14,3)7-8-19(11)24-9-10-25-19;1-11-13-6-5-12-14(16-19-22-24(4)21-16)23(3)20-15(12)17(13,2)7-8-18(11)25-9-10-26-18;1-9-13-6-5-12-14(17-21-20-10(2)24-17)23(4)22-16(12)18(13,3)7-11-8-19-25-15(9)11;1-9-12-7-6-11-14(17-21-20-10(2)25-17)23(5)22-16(11)18(12,3)8-13(19-4)15(9)24;1-9-13-6-5-12-14(17-20-19-10(2)25-17)22(4)21-16(12)18(13,3)7-11(8-23)15(9)24;1-9-12-6-5-11-14(16-19-18-10(2)23-16)21(4)20-15(11)17(12,3)8-7-13(9)22/h11,14H,5-10H2,1-4H3;11,13H,5-10H2,1-4H3;8-9,13H,5-7H2,1-4H3;9,12-13H,6-8H2,1-3,5H3;8-9,13,23H,5-7H2,1-4H3;9,12H,5-8H2,1-4H3/b;;;;11-8-;/t11-,14-,18-;11-,13-,17-;9-,13-,18-;9-,12-,13?,18-;9-,13-,18-;9-,12-,17-/m000000/s1
InChIKeyBONXUZHUOWPHBD-NFCMHCCRSA-N
XLogP15.06
TPSA483.87 Ų
H-Bond Donors1
H-Bond Acceptors41
Rotatable Bonds6
Heavy Atoms150
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002052.47
LogP ≤ 515.06
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1041

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'keto_keto_beta_D(5)', 'substructure': 'N/A'}, {'alert_name': 'acyclic_C=C-O', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one?
The IUPAC name of (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one (CID 157413338) is (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one.
What is the SMILES notation for (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one?
The canonical SMILES for (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one is C[C@H]1[C@@H]2CCc3c(nn(C)c3-c3nnn(C)n3)[C@@]2(C)CCC12OCCO2.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)C/C(=C/O)C(=O)[C@@H](C)[C@@H]2CC3)o1.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)CCC(=O)[C@@H](C)[C@@H]2CC3)o1.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)CCC4(OCCO4)[C@@H](C)[C@@H]2CC3)o1.Cc1nnc(-c2c3c(nn2C)[C@@]2(C)Cc4cnoc4[C@@H](C)[C@@H]2CC3)o1.[C-]#[N+]C1C[C@]2(C)c3nn(C)c(-c4nnc(C)o4)c3CC[C@H]2[C@H](C)C1=O.
What is the InChIKey of (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one?
The InChIKey is BONXUZHUOWPHBD-NFCMHCCRSA-N. The full InChI is InChI=1S/C19H26N4O3.C18H26N6O2.2C18H21N5O2.C18H22N4O3.C17H22N4O2/c1-11-14-6-5-13-15(17-21-20-12(2)26-17)23(4)22-16(13)18(14,3)7-8-19(11)24-9-10-25-19;1-11-13-6-5-12-14(16-19-22-24(4)21-16)23(3)20-15(12)17(13,2)7-8-18(11)25-9-10-26-18;1-9-13-6-5-12-14(17-21-20-10(2)24-17)23(4)22-16(12)18(13,3)7-11-8-19-25-15(9)11;1-9-12-7-6-11-14(17-21-20-10(2)25-17)23(5)22-16(11)18(12,3)8-13(19-4)15(9)24;1-9-13-6-5-12-14(17-20-19-10(2)25-17)22(4)21-16(12)18(13,3)7-11(8-23)15(9)24;1-9-12-6-5-11-14(16-19-18-10(2)23-16)21(4)20-15(11)17(12,3)8-7-13(9)22/h11,14H,5-10H2,1-4H3;11,13H,5-10H2,1-4H3;8-9,13H,5-7H2,1-4H3;9,12-13H,6-8H2,1-3,5H3;8-9,13,23H,5-7H2,1-4H3;9,12H,5-8H2,1-4H3/b;;;;11-8-;/t11-,14-,18-;11-,13-,17-;9-,13-,18-;9-,12-,13?,18-;9-,13-,18-;9-,12-,17-/m000000/s1.
What are the key properties of (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one?
(5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one has a molecular weight of 2052.47 g/mol, XLogP of 15.06, 6 rotatable bonds, 1 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for (5aS,6S,9aS)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one;(5aS,6S,10aS)-2,6,10a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,10-tetrahydro-4H-indazolo[7,6-f][1,2]benzoxazole;(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(5-methyl-1,3,4-oxadiazol-2-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5'aS,6'S,9'aS)-2',6',9'a-trimethyl-3'-(2-methyltetrazol-5-yl)spiro[1,3-dioxolane-2,7'-4,5,5a,6,8,9-hexahydrobenzo[g]indazole];(5aS,6S,8Z,9aS)-8-(hydroxymethylidene)-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-5,5a,6,9-tetrahydro-4H-benzo[g]indazol-7-one;(5aS,6S,9aS)-8-isocyano-2,6,9a-trimethyl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-4,5,5a,6,8,9-hexahydrobenzo[g]indazol-7-one is sourced from PubChem (CID 157413338), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).